Christopher P. F. Marinangeli & Peter J. H. Jones: Functional food ingredients as adjunctive therapies to pharmacotherapy for treating disorders of metabolic syndrome. Ann Med 2010; 42: 317–333.
It has come to our attention that the top-most oval in should have read ‘Atherogenic Dyslipidemia’ as shown below:
It has come to our attention that the mechanisms for prescription medications in should have been depicted as shown below:
On page 327, the third sentence of the ‘Medications versus tomato extract as adjunctive therapies for hypertension’ section should have read as follows:
In the same study, it should be noted that the 6% and 5% reductions in SBP and DBP observed with tomato extract are comparable to average reductions in SBP and DBP with prescription medications at 8.8 mmHg and 4.4 mmHg for thiazides, 9.2 mmHg and 6.7 mmHg for β-blockers, 8.5 mmHg and 4.7 mmHg for ACE inhibitors, 10.3 mmHg and 5.7 mmHg for angiotensin II-converting enzyme antagonists, and 8.8 mmHg and 5.9 mmHg for calcium blockers, respectively (139)—thus suggesting that concentrated tomato extract can complement hypotensive medications.
The authors, editors and publisher sincerely regret any inconvenience this may have caused our readers.